Small to Mid-Cap Biotechs Are Most Affected by Market Volatility
Equity Research Analyst, David Nierengarten, appeared on TD Ameritrade Networkto discuss his outlook on the healthcare sector . Watch his full comments here.
Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies. To learn more about the categories of information we collect and what we do with it, please see our Notice at Collection.OkPrivacy policy
